Scotland’s babies are now being screened for SMA – and England is next

The UK has reached a historic turning point in newborn care. Scotland has become the first nation in the UK to screen all newborn babies for Spinal Muscular Atrophy (SMA) – and now England has announced it will follow, three months earlier than expected. Here’s everything parents need to know.

What is SMA?

Spinal Muscular Atrophy (SMA) is a rare but devastating genetic condition that affects the nerves in the spinal cord. It causes progressive muscle weakness, affecting a baby’s ability to breathe, swallow and move. In its most severe form – Type 1 – symptoms typically appear between birth and six months of age.

Until recently, most babies were only diagnosed once symptoms had already appeared. By that point, irreversible damage had often already been done. Early detection is critical because available treatments can only prevent, not reverse, motor neuron loss, meaning that every single day counts.

In countries where newborn screening for SMA is already in place, the difference in outcomes is stark. Babies identified at birth and treated early can go on to walk, breathe independently, and meet developmental milestones their unscreened peers simply cannot reach.

Scotland Makes History

Scotland is now the first part of the UK to screen newborn babies for SMA. The test began this week, with all parents now offered SMA screening for their newborns through the existing blood spot test, which is taken around day four after birth.

The Scottish Government and pharmaceutical company Novartis are funding a two-year evaluation to assess how well SMA screening can detect the condition earlier, allowing babies to receive treatment as soon as possible.

The screening is simple – it’s added to the heel prick test your baby already receives in the first days of life, which currently checks for a range of serious conditions. No extra needles, no extra appointments. If screening indicates SMA, the newborn screening laboratory at the Queen Elizabeth University Hospital in Glasgow will notify a paediatrician immediately, and families will be contacted to arrange a consultation within 48 hours.

All three disease-modifying treatments are now routinely available through NHS Scotland alongside newborn screening, meaning that any baby who tests positive will have immediate access to potentially life-changing care.

Subscribe to the Birthbabe Magazine to get all the latest news, expert-backed guidance and everything you need for motherhood – direct to your inbox.

What does this mean for families?

Giles Lomax, CEO of the charity SMA UK, described the enormity of this moment: babies diagnosed through newborn screening “will now have the opportunity to grow up without life-long health care needs and the complexity and challenges of living with SMA.”

According to the UK NSC, introducing newborn screening for SMA could prevent two babies each year from needing permanent ventilation. For those families, those are two lives transformed.

England’s screening brought forward to October 2026

And Scotland won’t be alone for long. In a huge announcement that sent shockwaves through the SMA community, Health Secretary Wes Streeting confirmed that screenings in England will be rolled out earlier than planned, beginning as part of in-service evaluations (ISE) from October 2026 instead of January 2027.

This acceleration represents a major milestone driven by years of sustained campaigning by SMA UK, the SMA community and other key stakeholders.

The proposal, led by the University of Oxford in partnership with SMA REACH UK, the University of Sheffield, the University of Warwick and King’s College London, sets out a phased rollout of SMA screening in England using seven existing newborn screening sites. By January 2028, these sites could screen 404,000 babies each year – 72% of England.

Jesy Nelson’s role in the fight

One of the most recent, high-profile voices in this campaign has been former Little Mix star Jesy Nelson, who became a patron of SMA UK after her twin daughters, Ocean Jade and Story Monroe Nelson, were diagnosed with the condition. Nelson announced in January that her daughters’ diagnosis would mean they are unlikely to ever be able to walk or regain their neck strength. Early treatment can help prevent some of the most devastating consequences of the condition.

On receiving the letter from Wes Streeting confirming the brought-forward timeline, Nelson celebrated the news on her Instagram story, describing it as “a big step forward” and saying: “I am so proud, as this is a major milestone for the SMA Community.”

Her openness about her daughters’ diagnosis has helped bring this issue to a far wider audience – and this announcement is, in part, a tribute to her courage, as well as all the families and organisations who have tirelessly campaigned for this change.

What about Wales and Northern Ireland?

The picture for Wales and Northern Ireland is still developing. SMA UK has said it will continue to work with governments and health systems across all four nations to ensure the programme is implemented quickly, consistently and equitably, so that every baby has the best possible start. Campaigning continues to ensure no baby is left behind based on where they live.

Why this matters so much

The UK has long lagged behind other countries on this issue. A powerful open letter published in The Lancet earlier this year, signed by leading SMA clinicians, made the case bluntly: babies born with SMA in the UK were being left behind, with the difference in outcomes compared to countries with newborn screening being not small, but life-changing.

That is finally beginning to change.

For any parent welcoming a new baby in Scotland right now, SMA screening is already happening. For families in England, October 2026 is the date to know. And for the families who have campaigned, often through unimaginable heartbreak, to make this happen – this moment is everything.

For more information, visit smauk.org.uk. If you have concerns about your baby’s development, always speak to your GP or health visitor.

Image: Supplied

Birthbabe is supported by the beautiful babes who enjoy our content. We only recommend products we genuinely rate. We may receive an affiliate commission.

Birthbabe does not provide medical advice, diagnosis, or treatment. The resources on our website are provided for informational purposes only. You should always consult with a healthcare professional regarding any medical diagnoses or treatment options. For general purposes only.

Was this helpful? Share the love:

Similar Posts

Birth Academy

Your body. Your baby. See what's coming next.​

Putting mamas first.

Scroll to Top